Stock FRTX FRESH TRACKS THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company Fresh Tracks Therapeutics, Inc.

Equities

FRTX

US10802T2042

Biotechnology & Medical Research

Delayed OTC Markets
Other stock markets
 12:22:05 2024-04-19 pm EDT 		5-day change 1st Jan Change
0.9001 USD -1.09% Intraday chart for Fresh Tracks Therapeutics, Inc. -1.09% +2.39%
Mar. 15 Fresh Tracks Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Fresh Tracks Therapeutics, Inc.(OTCPK:FRTX) dropped from S&P TMI Index CI

Business Summary

Fresh Tracks Therapeutics, Inc. is not engaged in any business activities. The Company is in the process of dissolution.

Number of employees: 4

Sales per Business

USD in Million2022Weight2023Weight Delta
Prescription Therapeutics
100.0 %
7 100.0 % 8 100.0 % +15.31%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
100.0 %
7 100.0 % 8 100.0 % +15.31%

Managers

Managers TitleAgeSince
Albert Marchio CEO
 Chief Executive Officer 72 20-11-30
Nancy Seretta CTO
 Chief Tech/Sci/R&D Officer - 15-12-31
Aaron Fox-Collis AUD
 Comptroller/Controller/Auditor - 20-06-30
Aron Aizenstat PRN
 Corporate Officer/Principal - -
Sue Fattor HRO
 Human Resources Officer - -

Members of the board

Members of the board TitleAgeSince
Albert Marchio CEO
 Chief Executive Officer 72 20-11-30

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 5,973,306 5,877,545 ( 98.40 %) 0 98.40 %

Shareholders

NameEquities%Valuation
Exploration Capital LLC
17.40 %
1,039,279 17.40 % 940 547 $
Telemetry Investments LLC
1.088 %
65,000 1.088 % 58 825 $
Deepak Chadha
0.3643 %
21,759 0.3643 % 19 692 $
David R. McAvoy
0.2741 %
16,371 0.2741 % 14 816 $
Robert Brown
0.1164 %
6,951 0.1164 % 6 291 $
ANGES, INC.
0.1094 %
6,535 0.1094 % 5 914 $
Monica Luchi
0.0509 %
3,042 0.0509 % 2 753 $
Ronald Blue Trust, Inc.
0.0153 %
916 0.0153 % 829 $
Merrill Lynch Investment Managers, Inc.
0.001607 %
96 0.001607 % 87 $
Nordea Investment Management AB
0.000084 %
5 0.000084 % 5 $

Company contact information

Fresh Tracks Therapeutics, Inc.

5777 Central Avenue Suite 102

80301, Boulder

+

http://www.frtx.com
address Fresh Tracks Therapeutics, Inc.(FRTX)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Bio Therapeutic Drugs

Quarterly earnings - Rate of surprise

Company calendar

Sector Bio Therapeutic Drugs

1st Jan change Capi.
FRESH TRACKS THERAPEUTICS, INC. Stock Fresh Tracks Therapeutics, Inc.
+2.39% 5.44M
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
-2.87% 102B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+1.89% 96.07B
ARGENX SE Stock argenx SE
-1.80% 21.66B
BIONTECH SE Stock BioNTech SE
-17.68% 20.77B
GENMAB A/S Stock Genmab A/S
-6.91% 18.53B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-42.00% 16.91B
BEIGENE, LTD. Stock BeiGene, Ltd.
-28.03% 13.79B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
-0.11% 13.33B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+19.59% 10.94B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. FRTX Stock
  4. Company Fresh Tracks Therapeutics, Inc.